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Gordonia spp. are a gram-positive coryne-
form bacteria, recently identified in three
patients as a cause of systemic infections (1,2),
including two associated with indwelling im-
plantable subcutaneous central venous catheters
(2). We report Gordonia spp.’s capacity to infect a
patient’s undamaged cardiac valve through an
implantable subcutaneous central catheter.
Case Report
The patient was a 31-year-old woman, who
had undergone splenectomy at age 9 years, for
severe double heterozygous hemoglobinopathy
(beta-thalassemia and hemoglobin E disease).
Multiple blood transfusions at that time were
complicated by hepatitis C with cirrhosis and
secondary hemochromatosis, treated at home
with twice weekly deferoxamine by subcutaneous
central venous catheter. Hemochromatosis was
complicated by diabetes, adrenal insufficiency,
and peripheral neuropathy. In September 1997,
the patient became ill with Staphylococcus
aureus  bacteremia associated with localized
renal and cutaneous abscesses; transesophageal
echocardiography showed neither valvular
vegetation nor a valvular defect suggestive of
endocarditis. The bacteremia was successfully
treated with intravenous fosfomycin, cefotaxime
and netilmicin, followed by ciprofloxacin and
oxacillin for 8 weeks. The subcutaneous central
venous port was also changed after 6 weeks of
treatment.
 The patient remained afebrile until Decem-
ber 1998, when fever and chills developed.
Physical examination 1 week after onset of
symptoms revealed a temperature of 39°C and a
new mitral systolic murmur. The site of the
subcutaneous central venous port showed no
signs of infection. Results of clinical laboratory
tests showed a leukocyte count of 31.4x109/L, an
erythrocyte sedimentation rate of 67 mm/h, and a
C-reactive protein plasma level <5 mg/L.
Transthoracic echocardiography revealed a
mitral valvular vegetation (10x5 mm). Two blood
cultures (one obtained from the central venous
catheter) were performed at admission. One
more peripheral blood sample was drawn for
culture 12 hours later. All three cultures were
positive for a gram-positive coryneform bacteri-
um showing no extensive branching. This
organism produced dry, raised, salmon-to-orange
colonies without aerial hyphae. As the organism
was weakly acid fast, according to the Kinyoun
acid-fast stain modified for aerobic actinomycet-
es, we presumptively identified this organism as
Rhodococcus  sp. sensu lato. According to disk
diffusion, the organism was susceptible to
Bacteremia and Endocarditis Caused by a
Gordonia Species in a Patient with a
Central Venous Catheter
Olivier Lesens,* Yves Hansmann,* Philippe Riegel,†
Rémy Heller,† Mohamed Benaissa-Djellouli,* Martin Martinot,*
Hélène Petit,‡ Daniel Christmann,*
*Service des Maladies Infectieuses et Tropicales, Clinique Médicale A,
Hôpitaux Universitaires, Strasbourg, France; †Laboratoire de Bactériologie,
Faculté de Médecine, ‡Service de Chirurgie Cardio-Vasculaire, Hôpitaux
Universitaires, Strasbourg, France
Address for correspondence: Olivier Lesens, Service des
Maladies Infectieuses et Tropicales, Clinique Médicale A,
Fédération des Services de Médecine Interne, Hôpital Civil, 1
place de l’Hôpital - B.P. 426- 67091 Strasbourg Cedex, France;
fax: 03 88 11 64 64; e-mail: olivier.lesens@wanadoo.fr.
We report the first case of endocarditis caused by a Gordonia species genetically
related to G. sputi but exhibiting some atypical biochemical features in a 31-year-old
woman with a central venous catheter. This unusual pathogen may be a new cause of
opportunistic infections in patients with severe underlying diseases.Dispatches
383 Vol. 6, No. 4, July–August 2000 Emerging Infectious Diseases
Table 1. Classification of the genus Gordonia
Present designated species (date) Former designated species (date)
Gordonia aichiensisa (1997) Gordona aichiensis (1994) ←   Rhodococcus aichiensis (1983)
Gordonia alkanivorans (1999) --
Gordonia amaraea (1997) Gordona amarae (1994) ←  Nocardia amarae (1980)
Gordonia bronchialisa (1997) Gordona bronchialis (1989) ←  Rhodococcus bronchialis (1980)
Gordonia desulfuricans (1999) --
Gordonia hirsutaa (1997) Gordona hirsuta (1996)
Gordonia hydrophobicaa (1997) Gordona hydrophobica (1995)
Gordonia polyisoprenivorans (1999) --
Gordonia rhizosphera (1998) --
Gordonia rubropertinctaa (1997) Gordona rubropertincta (1989) ←   Rhodococcus rubropertinctusb (1980)
Gordonia sputia (1997) Gordona sputi (1989) ←   Rhodococcus sputic (1975)
Gordonia terraea (1997) Gordona terrae (1989) ←  Rhodococcus terrae (1980)
aThe original spelling, Gordona, was changed to Gordonia in 1997 (5).
bOther former designations:Bacillus rubropertinctus, Serratia rubropertincta, Mycobacterium rubropertinctum, Proactinomyces
rubropertinctus, Nocardia rubropertincta.
cSynonym: Rhodococcus chubuensis.
penicillin G, amoxicillin, cefotaxime, ceftriaxone,
imipenem, gentamicin, netilmicin, ciprofloxacin,
vancomycin, and erythromycin but was resistant
to fosfomycin, ceftazidime, trimethoprim-sul-
famethoxazole, and streptogramin. By E-test, the
MICs of penicillin G, amoxicillin, and ceftriaxone
were 0.047, 0.064 and 0.25 µg/mL, respectively.
The patient was successfully treated with
intravenous amoxicillin (3 g, 4/day) and intrave-
nous netilmicin (150 mg, 2/day) for 1 week, then
with intravenous amoxicillin alone for 3 weeks.
This treatment was followed by home treatment
with 2 g perfusion of ceftriaxone for 2 weeks. The
central venous catheter was left in situ. At 1 year
follow-up, the patient was not infected with
Gordonia  sp., and echocardiographic findings
were consistent with mitral valve insufficiency
without oscillating intracardiac mass on valve.
To accurately identify the organism, we
analyzed the p-bromophenacyl esters of mycolic
acids of the isolate by using high-performance
liquid chromatography, obtaining a pattern
consistent with that of Gordonia sp. The number
of peaks and retention times were similar to
those exhibited by the G. sputi type strain ATCC
29627. Biochemical test results were positive for
the hydrolysis of urease and esculin but negative
for the hydrolysis of xanthine, adenine, tyrosine,
and hypoxanthine. When inoculated with
aerobic, low-peptone carbohydrate slants, the
strain produced acid from trehalose but not from
L-rhamnose and D-mannitol. These biochemical
characteristics fit those of Gordonia species,
especially  G. bronchialis (3). To determine
partial 16S rRNA gene sequence, the two
eubacterial universal primers P8-27 (5'-AGA
GTT TGA TCC TGG CTC AG-3') and P1392-1372
(5'-AAG GCC CGG GAA CGT ATT CAC-3') were
used for the amplification, then a direct
sequencing method with an internal primer
P535-514 (5'-GTA TTA CCG CGG CTG CTG GGC
AC-3') 5' labeled with fluorescein isothiocyanate
was performed (4). The sequence obtained
coincides with the 450 5' base pairs of the 16S
rRNA gene and matches totally that of G. sputi
present in the GenBank-EMBL database. This
sequence did not match other bacterial se-
quences, including those of other Gordonia
species. The sequence of the isolate differed from
the sequence of the G. aichiensis type strain by
two nucleotides. DNA–DNA similarity experi-
ments, according to the stringent nuclease S1
method, showed 55% DNA relatedness
with G. sputi type strain and less than 28% with
the type strain of other species including
G. aichiensis. (The genetic definition of a species
is more than 70% DNA similarity.) Thus, this
isolate does not fit in any of the recognized
Gordonia species, although it is taxonomically
close to G. sputi.
Conclusions
The recent differentiation of Gordonia sp. as
a distinct genus is the outcome of a taxonomic
history complicated by several reclassifications
(Table 1). Twelve organisms now belong to the
genus Gordonia, including three species discovered
in 1999 (5-9). To review the spectrum of clinical
diseases in humans caused by Gordonia spp., we
performed a Medline search for 1966 to 1999,
using all the designations included in Table 1.
Only G. bronchialis (10), G. rubropertincta (11),Dispatches
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Table 2. Types of infection caused by Gordonia species and patients’ underlying conditions
Cases Age
Type of infection  (No.) (yrs) Gordonia species Underlying conditions Authors
Sternal wound 7 51-68 G. bronchialis Surgery Richet et al. (10)
Mediastinitis 1 54 G. sputi Surgery Kuwabara et al. (12)
Brain abscess 1 40 G. terrae None Drancourt et al. (14)
1  3 G. terrae Cerebral tumor Drancourt et al. (13)
Lung infection 1 29 G. rubropertincta Tuberculosis Hart et al.(11)
Bacteremia due to 2 43 Gordonia spa Breast and ovarian cancer Buchman et al. (2)
  central venous 65 G. terrae Chronic intestinal pseudo-
  catheter   obstruction syndrome
Bacteremia due to 1 34 G. sputi Metastatic melanoma Riegel et al. (1)
  cutaneous IL2 treatmentb
  lesions
Skin infection 1   7 G. terrae None Martin et al. (16)
aNot identified.
bIL2 = interleukin-2.
G. sputi (1,12), and G. terrae (2,13,14) have been
shown to be pathogenic in humans (Table 2).
They are derived from soil and may also be
isolated in the sputa from patients with chest
disorders (15). In an outbreak of sternal-wound
infections (10), G. bronchialis was isolated from
the hand, scalp, and vagina of a nurse as well as
from her dog.
Systemic Gordonia spp. infections have been
described in three patients. Buchman et al. (2)
reported two cases of Gordonia spp. bloodstream
infection associated with a Hickman catheter in
two immunocompetent patients receiving long-
term parenteral nutrition. Both strains were
susceptible to vancomycin and gentamicin. In one
case, the Gordonia  sp. isolated from blood
cultures and from a broth culture of the catheter
tip was not clearly identified but was close to
G. rubropertincta. The patient received intrave-
nous vancomycin for 5 days and intravenous
gentamicin for 19 days; the catheter was removed
after 2 days. In the second case, the microorgan-
ism isolated from blood cultures was identified as
G. terrae, and the patient was treated with
intravenous vancomycin for 6 weeks with the
catheter left in situ.
The only case of bacteremia caused by G. sputi
was described in a 34-year-old immunocompro-
mised patient (1) with metastatic melanoma
treated with intravenous interleukin-2. The
bacterium was thought to have reached the
bloodstream through extensive desquamative
skin rashes caused by the interleukin-2
treatment or by contamination of the catheter,
although cultures from these specimens were
negative. Because G. sputi was susceptible to
ß-lactams, vancomycin, aminoglycosides, doxy-
cycline, and rifampicin, the patient was first
treated with amoxicillin-clavulanate (1,000 and
125 mg, respectively, every 3 hours). After 1 week
of treatment, a second set of blood cultures
yielded the same organism, and the treatment
was changed to a combination of amikacin and
piperacillin, which was successful (1). As with
other Gordonia species, G. sputi may be isolated
in the sputum of patients with pulmonary disease
(15). Mediastinitis caused by G. sputi after
coronary artery bypass grafting was recently
described in an immunocompetent patient (12).
The patient was treated with cefmetazole sodium
(2 g per day for 3 weeks) and piperacillin
sodium (2 g per day for 2 weeks) after surgical
soft tissue debridement.
In our case, Gordonia sp. systemic infection
associated with an implantable subcutaneous
central venous catheter was complicated by
endocarditis. The diagnosis was assessed as
definitive on the basis of Duke criteria (one major
and three minor, including echographic evidence
of an oscillating intracardiac mass with a new
regurgitant murmur, two persistently positive
blood cultures yielding Gordonia  sp.,  fever
>38°C, and intravenous deferoxamin use). Our
patient had neither neutropenia nor immunosup-
pressive medications, but underlying diseases
may have impaired the immune system and
facilitated infection. The bacteremia may be
caused by manipulations of the implantable
subcutaneous central venous catheter during
routine home use. However, even if no otherDispatches
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source for the bacteremia had been evident, no
inflammation was observed at the port site, and
semiquantitative culture was not available. An
environmental investigation was not performed.
We conclude that Gordonia spp. may cause
opportunistic infections, in particular bacteremia
and endocarditis, in patients with severe
underlying diseases and indwelling central
catheters.
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